Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases

pharmafocusasiaFebruary 21, 2019

Tag: Exicure , Dermelix Biotherapeutics , skin diseases , nucleic acid

PharmaSources Customer Service